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Purpose: To evaluate ocular response and subject acceptance of a new multipurpose disinfecting solution
(MPDS), Complete Revitalens (RevitaLens OcuTec in the US Market), for soft contact lens care in a large
“real practice” setting.
Method: This is an international multi-center, open-label assessment carried out in 10 countries across
Europe and in the USA. Up to 10 subjects who were currently wearing soft contact lenses for at least 1
year and using a MPS as a lens care system were included at each investigational site.
Results: Data were collected from 996 European and 1985 American wearers, 75% of those patients wore
silicone hydrogel contact lenses. Approximately 94% found the new MPDS “somewhat more effective”
to “much more effective” in keeping contact lenses feeling clean and 88% found the new MPDS to be
somewhat more effective to much more effective in keeping their lenses feeling comfortable in the
evening. Over 93% reported an improvement in vision clearness in the evening after approximately 1
month while using the new MPDS. Wearers with grade 2, 3 or 4 of severity decreased by 11.3, 6.4 and
9.8% over 1 month period for redness, burning and irritation, respectively. After approximately 1 month
83% of wearers declared that they would prefer to use the new MPDS.
Conclusions: Over 88% felt their lenses were somewhat to much more comfortable at the end-of-day and
94% found the new MPDS to be somewhat to much more effective in keeping their lenses feeling clean
compared to their previous care system.
© 2013 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Multipurposedisinfecting solutions (MPDS) for contact lens care
have been one of the areas in the contact lens industry that has
experienced more innovations. Part of these advances have been
driven by several contamination outbreaks, but also by the chal-
lenges imposed by the newgenerations of silicone hydrogel (Si-Hy)
contact lenses and the compatibility issues linked to the interac-
tion between MPDS constituents, the contact lens materials and
the ocular surface [1,2].
The commitment of developing more efﬁcacious MPDS that are
also fully compatible with the ocular surface when used in combi-
nation with the growing category of Si-Hy contact lens materials
puts a lot of pressure on the industry to develop high perfor-
mance products. Recently, new MPDS that attempt to improve the
safety and efﬁcacy of soft CL have been developed and their results
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are promising either from the antimicrobial and/or clinical perfor-
mance perspective [3–5].
In a recent study we have evaluated ex vivo dehydration,
pre-lens tear stability, optical quality of the eye and subjective
performance with two new double biocide MPDS including Com-
plete Revitalens MPDS. The outcomes showed that both solutions
provided excellent preservation of pre-lens tear ﬁlm stability and
consistentopticalqualityof theeyeover1monthofwearof Lotraﬁl-
con B Si-Hy contact lens. Furthermore, voluntaries reported less
than1.5 points of reduction in end-of-daydrynesswhich is remark-
able considering that all of them were neophytes.
The present study was designed to evaluate in the “real practice
environment” the ocular safety, efﬁcacy and subject acceptance of
Complete RevitalensMPDS, also knownasRevitaLensOcuTec in the
USA, in subjects currently wearing soft contact lenses and using a
multipurpose contact lenses solution.
2. Methods
This was an international multi-centre, open-label assessment
conducted across Europe and USA. According to the protocol, up to
1367-0484/$ – see front matter © 2013 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.
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Table 1
Composition of MPDS used in the study.
COMPLETE® Revitalens MPDS
Preservative Polyquaternium-1: 0.0003% Alexadine
0.00016%
Buffer Boric acid, sodium borate decahydrate,
trisodium citrate dehydrate.
Chelating agent EDTA
Surfactant Tetronic 904
Tear ﬁlm electrolytes Sodium chloride
Other Rub-and-rinse
10 subjects currentlywearing soft contact lenses and using amulti-
purpose contact lens solution, were included in this assessment by
each participating Eye Care Professional and asked to change from
their habitual care system to Complete Revitalens MPDS for the
duration of the study. Technical details of the MPDS are available
in Table 1.
Inclusion criteria required that prior to enrollment subjects had
a history of wearing soft contact lenses for 12 months or more;
lens reﬁt subjects had worn the same soft contact lens brand, ﬁt
and refractive correction for 6 months or more; subjects had been
using a multipurpose contact lens solution to care for their lenses.
Exclusion criteria included subjects with a history of wearing soft
contact lenses for less than 12months; reﬁt subjectswho hadworn
their current soft contact lens brand, ﬁt and correction for less
than 6 months; and subjects who were using a hydrogen peroxide
cleaning system.
Each Eye Care Professional examined the subjects according
to his/her standard clinical practice. At the initial and ﬁnal visits
(approximately 30 days from initial visit) the Eye Care Professional
recorded the overall severity of the subject ocular sign (redness)
and symptoms (burning, irritation, and discomfort). In addition, at
each visit the Eye Care Professional and/or their staff asked each
subject a series of questions regarding the multipurpose contact
lens solution they were using.
After explaining the nature of the assessment the wearers were
asked to sign the consent form. Two questionnaires were admin-
istered to volunteers; one at the baseline visit when the new
MPDS solutionwas dispensed (baseline visit) and another one after
approximately 1 month of use of the new MPDS (follow-up visit).
At baseline and at follow-up visit, an examination was performed
to evaluate the status of the ocular surface with special attention to
conjunctival redness graded from 0 to 4 according to Efron Grading
Scales.
Statistical analysiswasconductedusing JMPsoftwarev.6.0 (JMP,
Cary, NC). Demographic data and study variables were analyzed on
subjects who complete the initial and follow-up visit. Descriptive
statistics (i.e., mean, standard deviation, etc.) were obtained for all
continuous variables and frequencies for all categorical variables
collected in this trial. Efﬁcacy was assessed by evaluating changes
from baseline for all variables. Subject acceptance was assessed
by evaluating subjects’ evaluation of Complete Revitalens MPDS.
Statistical signiﬁcance was set for values of ˛<0.05.
3. Results
A total of 2981 wearers were assessed in this study. Distribution
of wearers across countries, demographic information and contact
lens experience for the sample collected are listed in Table 2. About
70%of the surveyedvolunteerswere female andapproximately69%
of all wearers had worn lenses for over 5 years before enrollment
in this assessment.
Of the 2666 wearers whose previous contact lenses were iden-
tiﬁed, 74.8% were wearing silicone-hydrogel contact lenses and
25.2% were wearing conventional hydrogel contact lenses; for 315
wearers (10.6%) the habitual contact lenses could not be identi-
ﬁed. Reported wearing time at baseline with their habitual contact
lenses was 12–15h/day in 51.3% of the wearers, while 17.2%
reported that they wore their lenses for over 15h/day. Regarding
their habitual care system, 33.9% used Optifree Replenish, 16.3%
Optifree Express, 9.1% ReNu Fresh, 5.4% Biotrue, 5.2% ReNu Multi-
plus, 4.6% Solocare and 2.9% ReNu Sensitive accounting altogether
for 77.4%; further 16.1% were identiﬁed as generic/store brand
while the remaining 6.5% were other products accounting for less
than 2% each. About 35% of the wearers enrolled reported to use
some kind of rewetting drops at their baseline visit.
Volunteers used the new MPDS for an average of 37.8±18 days
at the moment of the ﬁnal assessment and the results were com-
pared to the initial responses given at the baseline visit.
Fig. 1 shows the change in conjunctival redness as assessed by
the practitioner as well as burning sensation and irritation self-
reported by the wearer. There was a signiﬁcant increase in the
proportion of wearers with grade 0 of ocular redness, motivated
by also signiﬁcant reduction in wearers with grade 1 and grade 2
levels of ocular redness, burning and irritation experienced with
the new solution. There was a statistically signiﬁcant reduction in
redness, burning and irritation from baseline to the follow-up visit
after approximately 1 month (p<0.001, paired T-test).
Fig. 2 shows the comparativeperceptionof thewearer regarding
cleaning efﬁcacy and comfort with the new solution against their
previous solution. In this case, 93.5% reported that they felt the new
solution was somewhat effective to much more effective in keep-
ing their lenses feeling clean while 90.2% of the volunteers enrolled
reported that they felt the new solution was somewhat effective to
much more effective in keeping their lenses feeling comfortable
compared to the solution they were previously using. There was a
statistically signiﬁcant reduction inoculardiscomfort frombaseline
to the follow-upvisit after approximately1month (p<0.001,paired
Table 2
Demographic data and contact lens wearing experience by country.
Country n Age Female Wearing CL ≤5
years
Wearing CL >5
years
Austria 42 34.7 ± 13 61.9% 57.2% 42.9%
Belgium 14 42.6 ± 19 80.0% 13.4% 86.7%
England 39 45.0 ± 14 66.7% 33.3% 66.7%
France 175 38.5 ± 14 65.9% 40.0% 60.0%
Germany 287 34.8 ± 12 68.3% 48.8% 51.2%
Italy 248 34.6 ± 12 64.1% 47.2% 52.8%
Portugal 8 21.8 ± 2 75.0% 87.5% 12.5%
Spain 159 32.6 ± 13 69.8% 46.6% 53.4%
Sweden 10 25.3 ± 6 50.0% 40.0% 60.0%
Switzerland 12 31.3 ± 10 58.3% 33.3% 66.7%
USA 1985 36.2 ± 13 71.8% 24.3% 75.7%
Average total 2979 35.9 ± 13 71.1% 31.4% 68.6%
Author's personal copy
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Fig. 1. Change in grades of redness, burning and irritation after approximately 1
month with Complete Revitalens MPDS.
T-test). This is noteworthy considering that the levels of comfort
reported by thewearers at enrollmentwas considered comfortable
to very comfortable by 85.9%, 73.5% and 41.4% of the volunteers in
the morning, afternoon and evening, respectively (Fig. 3A). After
approximately 1 month using the new solution 93.4%, 91.9% and
87.9% of the volunteers reporting they felt their lenses somewhat
more comfortable to much more comfortable with the new solu-
tions in the morning, afternoon and evening, respectively (Fig. 3B).
Thewearers also reported their subjective sensation concerning
clearness of vision with their lenses at baseline and after approx-
imately 1 month using the new MPDS. Again, despite the good
subjective perception of vision clearness at study entry (Fig. 4A),
96.8%, 95.3% and 93% showed an improvement in this parameter
in the morning, afternoon and evening, respectively after approxi-
mately 1 month using the new MPDS (Fig. 4B).
4. Discussion
The outcomes from this study represent a singular opportunity
for eye care professionals to be able to participate in the assess-
ment of ocular safety, efﬁcacy and subject acceptance of a new
MPDS product and provide a “real-world” insight regarding the
acceptance of these products in a large cohort.
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Fig. 2. Change in feeling clean and comfortable after approximately 1 month with
Complete Revitalens MPDS.
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Fig. 3. Comfort at baseline with the wearer’s MPS (A) and change in comfort after
approximately 1 month with Complete Revitalens MPDS (B).
Multipurpose disinfection solutions have dominated the global
market for the last decade, accounting for over 70% of all
contact lens wearers in most countries. Despite the increase in the
global trends for daily disposable soft contact lenses [6] frequent
replacement continues to represent themajority of ﬁttings [7], thus
requiring a care system. MPDS have evolved to a convenient form
of cleaning, disinfecting and conditioning contact lenses in a single
product. Indeed, the data from the Contact Lens Fitting Survey Con-
sortium show that over 80% of the care systems prescribed consist
of multipurpose solutions [7].
An effective and safe care solution is fundamental for a satis-
factory contact lens wear experience, but their components can
also interact with the contact lens material. Si-Hy contact lenses
are thought to interact in a different way with MPDS such that can
be a cause of ocular discomfort, irritation and even inﬂammation
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Fig. 4. Subjective vision at baseline with wearer’s previous MPS (A) and change in
vision self-perception after approximately 1 month with Complete Revitalens (B).
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[8]. Thus, it is of primary importance to assess the compatibility
of new products with these types of materials. As a result of their
unique composition and the need of surface treatments in some
cases, Si-Hy contact lenses have a pattern of deposit adsorption
much different from conventional hydrogels [9,10]. The efﬁcacy of
MPS care systems in cleaning the contact lenses is in agreement
with a study conducted by Nichols [11] showing that less than 10%
ofwearers exhibited clinically signiﬁcant depositionwith a silicone
hydrogel contact lens combined with Complete MoisturePlus. The
present study is particularly interesting because of the population
sampled consisted mostly of Si-Hy contact lens wearers (66.7% of
the total sample or 74.8% of all identiﬁable lenses). Moreover, the
sample size capture in this study should represent well the actual
clinical population and the outcomes that might be expected by
clinicians when choosing to change the MPDS to wearers wear-
ing silicone hydrogel contact lens materials. Lebow and Schachet
evaluated 3 different multipurpose solutions combined with two
different conventional hydrogel high water content contact lens
materials [12]. Wearers reported a 57.1% preference for one of the
care regimes evaluated. It is not possible to compare our preference
resultswith those of the studymentioned considering the different
nature of each one. In a different study, Garofalo et al. evaluated the
symptoms reported by contact lens wearers with 4 different care
systems [13]. Three of the solutions used in that study (Opti-Free
Express, ReNu Multiplus and Solo-Care) account for 45% of all the
care systems reported in the present study.
The main outcomes reported here highlight the good perfor-
mance of the new MPDS for two of the most critical aspects of
contact lens wear; wearer’s comfort and vision self-perception. A
large proportion of the cohort reported an improvement in comfort
with the new care system. Our previous study showed a slight drop
of 1.5points in a10pointVisualAnalogueScale indryness after 10h
of wear from the dispensing visit to the 30 days visit in neophyte
wearers prescribed with a Si-Hy lens combined with Complete
Revitalens MPDS in one eye and Biotrue in the contralateral eye;
there were no signiﬁcant differences between solutions despite
their different composition and the incorporation of hyaluronic
acid as wetting agent in the former one. Campbell et al. compared
the comfort at insertion and removal with a new MPDS incorporat-
ingawettingagent. Theauthors found improvement in comfort and
decreasingdeposits [14]. Guillon andMaisahadalso reportedbene-
ﬁts from incorporating HPMC in the solution in terms of improving
comfort [15]. However, in our previous stud we did not observe
a signiﬁcant difference in comfort, wettability or optical quality
with Biotrue containing hyaluronic acid compared to Revitalens
[16]. The results of the present study reinforce the fact that this
new MPDS is able to enhance comfort in successful contact lens
wearers despite not incorporating any speciﬁc comfort agent in the
formulation.
Regarding vision perception, there was also a remarkable
improvement in the subjective perception of vision clearness. This
is not surprising considering our previous resultswhere the combi-
nation of the new MPDS products combined with a Si-Hy material
providedastablepre-lens tearﬁlmresulting inaconsistentuniform
pattern of optical aberrations over the month of study.
It is important to notice that all contact lens wearers included
in the study were successfully using their lenses. Despite this, the
new MPDS was able to improve comfort in most of the wearers to
a certain extent and quite signiﬁcantly in almost 50% of the sam-
ple. This is, is in agreement with Corbin et al. who showed that
switching to a new MPDS system might improve signiﬁcantly lens
comfort even in successful contact lens wearers. It is important to
highlight that Corbin’s study design was very similar to the present
study, although with a much smaller sample of 109 wearers [17].
Both studies support the evidence that it is safe to switch to a new
MPDS with minimal risks of non-satisfactory outcomes.
A limitationof this study is the fact that theplaceboeffect cannot
be ruled out as the wearers and clinicians were not masked and no
control group was used. This can inﬂuence the subject’s and even
the practitioner perception about the new product, thus rendering
an improvement with the new product, part of which might not be
directly related with an objective beneﬁt provided by the product
itself. Despite this, these results can be considered as representa-
tive of the clinical situation with the exception made to the fact
that in this case the wearer was not charged for the new solution,
which might again affect the positive opinion about the product;
in this context is signiﬁcant however, that over 80% of the wearers
would be willing to purchase the new product over the previous
one they were using before. Finally, there might be differences in
the criteria to judge ocular redness but this should not affect the
comparison between dispensing and follow-up visit by the same
practitioner.
In summary, the present report offers us a large amount of
information regarding the contact lens care habits followed by
soft contact lens wearers regarding their care systems and con-
tact lens wearing experience. According to these results, the new
MPDS under evaluation was able to show a signiﬁcant improve-
ment in comfort in wearers using some of the care systems more
commonly used world-wide. Furthermore, the solution seems to
produce satisfactory clinical results when combined with the most
frequently prescribed silicone hydrogel contact lenses which rep-
resented over 2/3 of the prescriptions considered in this study.
However, these results might not be directly applied to the real
clinical situation considering somemethodological limitations that
might overestimate the positive attitude of the subject towards a
new product provided free of charge. Thus, the placebo effect could
not be discarded with this protocol design and future randomized
and masked studies might evaluate the potential beneﬁt pointed in
this report.
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